The Jackson Laboratory
- Academic, tech transfer
- Public, NPO, govt., economic development
- Biotech – industrial & Environmental
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Diagnostics
- Investor (buy-side or sell-side research)
- Medical device or technology
- Institute, hospital research
- Digital health
The Jackson Laboratory is a global leader in mammalian genetics and human genomics, committed to advancing scientific discovery and its translation to benefit patients. We offer a robust portfolio of faculty-led innovations available for out-licensing and partnership, spanning neurodegeneration, regenerative medicine, cardiovascular and rare diseases, and infectious disease. Our Rare Disease Translational Center (RDTC) accelerates progress from gene discovery to therapy development through integrated, collaborative partnerships with academia, biotech, and patient foundations. Atlas™, our next-generation in vivo antibody discovery platform, delivers high-quality, fully human monoclonal and bispecific antibodies—accelerating timelines and enhancing candidate potential within existing workflows.



